There was a trend toward prophylactic G-CSF being associated with a decreased relative odds of severe neutropenia in a multivariate analysis (OR 0.33, 95% CI 0.10–0.93, P = 0.05)(Supplemental Table 1). This evidence concerns the gene CSF3 and neutropenia.